CONVERTING TISSUE-PLASMINOGEN ACTIVATOR TO A ZYMOGEN - A REGULATORY TRIAD OF ASP-HIS-SER

被引:82
作者
MADISON, EL
KOBE, A
GETHING, MJ
SAMBROOK, JF
GOLDSMITH, EJ
机构
[1] UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235
[2] UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235
[3] UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235
关键词
D O I
10.1126/science.8211162
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Unlike most serine proteases of the chymotrypsin family, tissue-type plasminogen activator (tPA) is secreted from cells as an active, single-chain enzyme with a catalytic efficiency only slightly lower than that of the proteolytically cleaved form. A zymogenic mutant of tPA has been engineered that displays a reduction in catalytic efficiency by a factor of 141 in the single-chain form while retaining full activity in the cleaved form. The residues introduced in the mutant, serine 292 and histidine 305, are proposed to form a hydrogen-bonded network with aspartate 477, similar to the aspartate 194-histidine 40-serine 32 network found to stabilize the zymogen chymotrypsinogen.
引用
收藏
页码:419 / 421
页数:3
相关论文
共 36 条
  • [1] INTERACTION BETWEEN SERINE (PRO)ENZYMES, AND KAZAL AND KUNITZ INHIBITORS
    ANTONINI, E
    ASCENZI, P
    BOLOGNESI, M
    GATTI, G
    GUARNERI, M
    MENEGATTI, E
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1983, 165 (03) : 543 - 558
  • [2] BEATTY K, 1980, J BIOL CHEM, V255, P3931
  • [3] THE SINGLE-CHAIN FORM OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR HAS CATALYTIC ACTIVITY - STUDIES WITH A MUTANT ENZYME THAT LACKS THE CLEAVAGE SITE
    BOOSE, JA
    KUISMANEN, E
    GERARD, R
    SAMBROOK, J
    GETHING, MJ
    [J]. BIOCHEMISTRY, 1989, 28 (02) : 635 - 643
  • [4] A SERINE PROTEASE TRIAD FORMS THE CATALYTIC CENTER OF A TRIACYLGLYCEROL LIPASE
    BRADY, L
    BRZOZOWSKI, AM
    DEREWENDA, ZS
    DODSON, E
    DODSON, G
    TOLLEY, S
    TURKENBURG, JP
    CHRISTIANSEN, L
    HUGEJENSEN, B
    NORSKOV, L
    THIM, L
    MENGE, U
    [J]. NATURE, 1990, 343 (6260) : 767 - 770
  • [5] HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH THE USE OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR IN TREATMENT OF ACUTE MYOCARDIAL-INFARCTION
    CALIFF, RM
    TOPOL, EJ
    GEORGE, BS
    BOSWICK, JM
    ABBOTTSMITH, C
    SIGMON, KN
    CANDELA, R
    MASEK, R
    KEREIAKES, D
    ONEILL, WW
    STACK, RS
    STUMP, D
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (03) : 353 - 359
  • [6] Carrell R.W, 1986, PROTEINASE INHIBITOR, P403
  • [7] PROBING THE MECHANISM AND IMPROVING THE RATE OF SUBSTRATE-ASSISTED CATALYSIS IN SUBTILISIN BPN'
    CARTER, P
    ABRAHMSEN, L
    WELLS, JA
    [J]. BIOCHEMISTRY, 1991, 30 (25) : 6142 - 6148
  • [8] ANALYSIS OF COAGULATION AND FIBRINOLYSIS DURING INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
    COLLEN, D
    BOUNAMEAUX, H
    DECOCK, F
    LIJNEN, HR
    VERSTRAETE, M
    [J]. CIRCULATION, 1986, 73 (03) : 511 - 517
  • [9] MOLECULAR MECHANISMS OF FIBRINOLYSIS AND THEIR APPLICATION TO FIBRIN-SPECIFIC THROMBOLYTIC THERAPY
    COLLEN, D
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, 33 (02) : 77 - 86
  • [10] AN INVESTIGATION INTO THE MINIMUM REQUIREMENTS FOR PEPTIDE HYDROLYSIS BY MUTATION OF THE CATALYTIC TRIAD OF TRYPSIN
    COREY, DR
    CRAIK, CS
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1992, 114 (05) : 1784 - 1790